Incidence rates for thromboembolic, bleeding and hepatic outcomes in patients undergoing hip or knee replacement surgery

Journal of Thrombosis and Haemostasis

Volumn 9, Issue 2, 2011, Pages 325-332

  Lanes, S ^a   Fraeman, K ^a   Meyers, A ^b   Ives, J Wood ^b   Huang, H Y ^b  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

Acute coronary syndrome; Hip replacement surgery; Knee replacement surgery; Stroke; Venous thromboembolism

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; DEEP VEIN THROMBOSIS; FEMALE; FOLLOW UP; HEALTH INSURANCE; HEPATITIS; HIP ARTHROPLASTY; HUMAN; INCIDENCE; JAUNDICE; KNEE ARTHROPLASTY; LIVER DISEASE; LIVER FAILURE; LIVER NECROSIS; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; THROMBOEMBOLISM; UNITED STATES; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; FEMALE; HUMANS; INCIDENCE; LIVER; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDIES; THROMBOEMBOLISM; YOUNG ADULT;

EID: 79251580991     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2010.04155.x     Document Type: Article

References (29)

1. Memtsoudis SG, Della Valle AG, Besculides MC, Gaber L, Laskin R. Trends in demographics, comorbidity profiles, in-hospital complications and mortality associated with primary knee arthroplasty. J Arthroplasty 2009; 24: 518-27.
2. Kim S. Changes in surgical loads and economic burden of hip and knee replacements in the US: 1997-2004. Arthritis Rheum 2008; 59: 481-8.
3. Labek G, Stockl B, Janda W, Hubl M, Thaler M, Liebensteiner M, Williams A, Pawelka W, Frischhut ST, Haselsteiner F, Schlichtherle R, Agreiter M, Abel J, Dorninger R, Sekyra K, Rosiek R, Mayr E, Hochgatterer R, Pfeiffer K-P, Krismer M, et al. Quality of datatsets [sic] for outcome measurement, market monitoring and assessment of artificial joint implants. European Arthroplasty Register, 2009.
4. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 381S-453S.
5. American Academy of Orthopaedic Surgeons. Clinical Guidelines on Prevention of Symptomatic Pulmonary Embolism in Patients Undergoing Total Hip or Knee Arthroplasty. Rosemont, IL: American Academy of Orthopaedic Surgeons; May 2007. Available at: Accessed 29 September 2010.
6. Medicare Quality Improvement Community. Surgical Care Improvement Project (SCIP) VTE prophylaxis options for surgery. QualityNet, 2009.
7. Merli G, Spyropoulos AC, Caprini JA. Use of emerging oral anticoagulants in clinical practice: translating results from clinical trials to orthopedic and general surgical patient populations. Ann Surg 2009; 250: 219-28.
8. White RH, Zhou H, Gage BF. Effect of age on the incidence of venous thromboembolism after major surgery. J Thromb Haemost 2004; 2: 1327-33.
9. Roumie CL, Mitchel E, Gideon PS, Varas-Lorenzo C, Castellsague J, Griffin MR. Validation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health data. Pharmacoepidemiol Drug Saf 2008; 17: 20-6.
10. Tirschwell DL, Longstreth WT Jr. Validating administrative data in stroke research. Stroke 2002; 33: 2465-70.
11. Varas-Lorenzo C, Castellsague J, Stang MR, Tomas L, Aguado J, Perez-Gutthann S. Positive predictive value of ICD-9 codes 410 and 411 in the identification of cases of acute coronary syndromes in the Saskatchewan Hospital automated database. Pharmacoepidemiol Drug Saf 2008; 17: 842-52.
12. Arnason T, Wells PS, van Walraven C, Forster AJ. Accuracy of coding for possible warfarin complications in hospital discharge abstracts. Thromb Res 2006; 118: 253-62.
13. Boulanger L, Hauch O, Friedman M, Foster T, Dixon D, Wygant G, Menzin J. Warfarin exposure and the risk of thromboembolic and major bleeding events among medicaid patients with atrial fibrillation. Ann Pharmacother 2006; 40: 1024-9.
14. Harley CR, Riedel AA, Hauch O, Nelson M, Wygant G, Reynolds M. Anticoagulation therapy in patients with chronic atrial fibrillation: a retrospective claims data analysis. Curr Med Res Opin 2005; 21: 215-22.
15. Zhang K, Young C, Berger J. Administrative claims analysis of the relationship between warfarin use and risk of hemorrhage including drug-drug and drug-disease interactions. J Manag Care Pharm 2006; 12: 640-8.
16. Daly LE. Confidence limits made easy: interval estimation using a substitution method. Am J Epidemiol 1998; 147: 783-90.
17. Kwong LM, Happe LE, Horblyuk R, Farrelly E. Decreased venous thromboembolism with injectable vs oral anticoagulation after discharge for major orthopedic surgery. J Arthroplasty 2008; 23: 25-30.
18. Oster G, Ollendorf DA, Vera-Llonch M, Hagiwara M, Berger A, Edelsberg J. Economic consequences of venous thromboembolism following major orthopedic surgery. Ann Pharmacother 2004; 38: 377-82.
19. Shorr AF, Kwong LM, Sarnes M, Happe L, Farrelly E, Mody-Patel N. Venous thromboembolism after orthopedic surgery: implications of the choice for prophylaxis. Thromb Res 2007; 121: 17-24.
20. Lohmander LS, Engesaeter LB, Herberts P, Ingvarsson T, Lucht U, Puolakka TJ. Standardized incidence rates of total hip replacement for primary hip osteoarthritis in the 5 Nordic countries: similarities and differences. Acta Orthop 2006; 77: 733-40.
21. Anderson FA Jr, White K. Prolonged prophylaxis in orthopedic surgery: insights from the United States. Semin Thromb Hemost 2002; 28(Suppl. 3): 43-6.
22. Carandang R, Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Kannel WB, Wolf PA. Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA 2006; 296: 2939-46.
23. Garcia Rodriguez LA, Varas-Lorenzo C, Maguire A, Gonzalez-Perez A. Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population. Circulation 2004; 109: 3000-6.
24. Testa L, Andreotti F, Biondi Zoccai GG, Burzotta F, Bellocci F, Crea F. Ximelagatran/melagatran against conventional anticoagulation: a meta-analysis based on 22639 patients. Int J Cardiol 2007; 122: 117-24.
25. Amin AN, Stemkowski S, Lin J, Yang G. Inpatient thromboprophylaxis use in US hospitals: adherence to the seventh American College of Chest Physician's recommendations for at-risk medical and surgical patients. J Hosp Med 2009; 4: E15-21.
26. Rahme E, Dasgupta K, Burman M, Yin H, Bernatsky S, Berry G, Nedjar H, Kahn SR. Postdischarge thromboprophylaxis and mortality risk after hip- or knee-replacement surgery. CMAJ 2008; 178: 1545-54.
27. Eikelboom JW, Karthikeyan G, Fagel N, Hirsh J. American Association of Orthopedic Surgeons and American College of Chest Physicians guidelines for venous thromboembolism prevention in hip and knee arthroplasty differ: what are the implications for clinicians and patients? Chest 2009; 135: 513-20.
28. Weber KL, Zuckerman JD, Watters WC 3rd, Turkelson CM. Deep vein thrombosis prophylaxis. Chest 2009; 136: 1699-700.
29. Eikelboom JW, Hirsh J. Deep vein thrombosis prophylaxis [reply]. Chest 2009; 136: 1700.